Nasdaq

20 stories about Nasdaq
ברק עילם מנכל נייס

Nice Extends Mattersight Tender Offer for the Fourth Time

25.06.18|Dror Reich
The Israeli software company announced the acquisition agreement in April, but has been held back by the American regulator again and again
נאסד"ק וול סטריט

After Hitting New Low, Interception Company Ability Jumps on Nasdaq

25.06.18|Dror Reich
The company closed at $2.16 on Wednesday and at $4.99 on Friday, and is currently almost 10% up in pre-trading
אבישי אברהמי מ מייסדי ו מנכל חברת וויקס

Wix Looking to Raise $385 Million in Private Offering

24.06.18|Lilach Baumer
In May, Wix published its first-quarter report for 2018, reporting revenue of $137.8 million, up 49% from a year earlier
נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich
Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
אייל ולדמן מלאנוקס

Mellanox and Starboard Nearing Agreement Over Board Seats, Report Says

18.06.18|Dror Reich
The two companies had been brawling over the makeup of Mellanox’s board since Starboard became the chipmaker’s largest shareholder in November
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering

17.06.18|Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
default image

Verint Rises on Earnings, CEO Declines to Comment on NSO Deal

10.06.18|Dror Reich
In a Thursday earnings call Verint CEO Dan Bodner dodged questions about potential acquisition of NSO Group, calling it "rumors"
Strata Skin סטראטה סקין דולב רפאלי

Medtech Investment Firm Acclemed Leads $17 Million Round for Derma Company Strata

30.05.18|Meir Orbach
Following the round, Acclemed became Strata's largest shareholder
default image

Surveillance Company Verint Negotiating $1 Billion Merger with Israeli NSO Group

28.05.18|Orr Hirschauge and Amarelle Wenkert
NSO develops and sells cyber attack tools that can be used to gather intelligence from mobile phones
תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
קורנית דיגיטל

Kornit Digital Reports Strong Sales of New Industrial Printer

10.05.18|Hezi Sternlicht
Revenue in the first quarter exceeded expectations as the maker of industrial inkjet printers for the garment industry saw high demand for its new machine
אבישי אברהמי מנכ"ל וויקס

Website Builder Wix’s Quarterly Revenue Is Up 49%

09.05.18|Asaf Shalev
The Israel-based tech company reported an uptick in the number of paid subscribers
ועידת התחזיות 2018 אשר לוי מנכ"ל אורבוטק

Orbotech Reports Strong Financial Results Ahead of Acquisition

09.05.18|Dror Reich
The Israel-based technology firm reports its last numbers before the close of the $3.4 billion deal with KLA-Tencor Corporation
default image

Tower Semiconductor Quarterly Financials Fall Short of Estimates

07.05.18|Dror Reich
The Israel-based company saw its revenue and net income drop from the same period last year
default image

Nasdaq-Listed Diabetes Monitoring Company Dario Considering Dual Tel Aviv Registration

03.05.18|Golan Hazani
Dario develops a device that enables users to test and track their blood-glucose levels in real time using their smartphones
אילן לוין מנכ"ל סטרטסיס

Stratasys Reports Disappointing Revenue Figures

02.05.18|Asaf Shalev
The 3D printer maker attributed weak earnings to underperformance in North America
default image

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Eloxx Wants to Raise $50 Million on Nasdaq

26.04.18|Meir Orbach and Lilach Baumer
The company intends to use the proceeds for research and development and for general corporate purposes
אייל ולדמן מלאנוקס

Mellanox CEO Rebuts Criticism by Activist Investor Starboard

22.04.18|Golan Hazani
Last week, Mellanox published its results for the first quarter of 2018, reporting $251 million in quarterly revenue, a 33% rise compared to the same quarter last year
קולפלנט דיו ביולוגי

Tissue Regeneration Company Collplant Wants to Delist From Tel Aviv Exchange

16.04.18|Lilach Baumer
The Israel-based biotech company is trading on Nasdaq since January following a $5 million investment agreement